Do electronic medication monitors improve tuberculosis treatment outcomes? Programmatic experience from China

被引:7
作者
Wang, Ni [1 ]
Shewade, Hemant Deepak [2 ,3 ]
Thekkur, Pruthu [2 ,3 ]
Zhang, Hui [1 ]
Yuan, Yanli [4 ]
Wang, Xiaomeng [5 ]
Wang, Xiaolin [6 ]
Sun, Miaomiao [7 ]
Huang, Fei [1 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China
[2] Int Union TB & Lung Dis Union, Paris, France
[3] Union South East Asia Off, New Delhi, India
[4] Jilin Res Inst TB Control, Changchun, Peoples R China
[5] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Peoples R China
[6] Fourth Peoples Hosp Ningxia Hui Autonomous Reg, Yinchuan, Ningxia, Peoples R China
[7] PATH China Program, Beijing, Peoples R China
来源
PLOS ONE | 2020年 / 15卷 / 11期
关键词
ADHERENCE;
D O I
10.1371/journal.pone.0242112
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background In China, an indigenously developed electronic medication monitor (EMM) was used. EMM recorded each time the device was opened (no real time data), offering an indirect measure of tuberculosis treatment adherence. Previous study in China showed that the EMM uptake was satisfactory, missing adherence data were common in the information management system (25%) and shift to directly observed therapy (DOT) based on poor adherence documented by EMMs were seldom. Objectives Among people with tuberculosis notified in 30 counties (July-December 2018) where EMM supported self-administered therapy (SAT) was suggested to all eligible (no communication impairment, ambulatory), we assessed the relative differences in unfavourable outcomes and deaths among those started on EMM at baseline (within first month of diagnosis) when compared to SAT alone. Methods This was a cohort study using secondary data. We employed an intention to treat analysis, and used modified Poisson regression with robust variance estimates to assess the association. Results Of 1810 eligible people, 1047 used EMM at baseline and of them, 216 (20.1%) stopped using EMM midway. Of 763 people who did not use EMM at baseline, 267 (35.0%) started using EMM later during the treatment. Among those who started using EMM at baseline, 6.3% [95% CI: 4.9, 8.0] had unfavourable outcomes compared to 6.7% [95% CI: 5.1, 8.8] among those who did not (p = 0.746). Lesser deaths were observed in people who started EMM at baseline when compared to those who did not: 2.5% [95% CI: 1.7, 3.7] versus 3.5% [95% CI: 2.4, 5.2], p = 0.191. The lack of association remained after adjusting for potential confounders (occupation, TB classification and TB category). Conclusion Under programmatic settings, we did not find significant differences in the outcomes. Optimization of EMMs by shifting to DOT when indicated, addressing the issue of missing data and ensuring continuous use is required.
引用
收藏
页数:11
相关论文
共 19 条
  • [1] Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies
    Alipanah, Narges
    Jarlsberg, Leah
    Miller, Cecily
    Nguyen Nhat Linh
    Falzon, Dennis
    Jaramillo, Ernesto
    Nahid, Payam
    [J]. PLOS MEDICINE, 2018, 15 (07)
  • [2] [Anonymous], 2014, Definitions and reporting framework for tuberculosis - 2013 revision
  • [3] Retrospective Return on Investment Analysis of an Electronic Treatment Adherence Device Piloted in the Northern Cape Province
    Broomhead, Sean
    Mars, Maurice
    [J]. TELEMEDICINE AND E-HEALTH, 2012, 18 (01) : 24 - 31
  • [4] Electronic Medication Packaging Devices and Medication Adherence A Systematic Review
    Checchi, Kyle D.
    Huybrechts, Krista F.
    Avorn, Jerry
    Kesselheim, Aaron S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (12): : 1237 - 1247
  • [5] Enhancing management of tuberculosis treatment with video directly observed therapy in New York City
    Chuck, C.
    Robinson, E.
    Macaraig, M.
    Alexander, M.
    Burzynski, J.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (05) : 588 - 593
  • [6] Expert Panel on Neurologic Imaging, 2017, J AM COLL RADIOL, V14, pS550
  • [7] Does phone messaging improves tuberculosis treatment success? A systematic review and meta-analysis
    Gashu, Kassahun Dessie
    Gelaye, Kassahun Alemu
    Mekonnen, Zeleke Abebaw
    Lester, Richard
    Tilahun, Binyam
    [J]. BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [8] Implementation and community involvement in DOTS strategy: a systematic review of studies in China
    Hou, W-L.
    Song, F-J.
    Zhang, N-X.
    Dong, X-X.
    Cao, S-Y.
    Yin, X-X.
    Liu, J-N.
    Lu, Z-X.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (11) : 1433 - 1440
  • [9] Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial
    Liu, Xiaoqiu
    Lewis, James J.
    Zhang, Hui
    Lu, Wei
    Zhang, Shun
    Zheng, Guilan
    Bai, Liqiong
    Li, Jun
    Li, Xue
    Chen, Hongguang
    Liu, Mingming
    Chen, Rong
    Chi, Junying
    Lu, Jian
    Huan, Shitong
    Cheng, Shiming
    Wang, Lixia
    Jiang, Shiwen
    Chin, Daniel P.
    Fielding, Katherine L.
    [J]. PLOS MEDICINE, 2015, 12 (09)
  • [10] Impact of a Daily SMS Medication Reminder System on Tuberculosis Treatment Outcomes: A Randomized Controlled Trial
    Mohammed, Shama
    Glennerster, Rachel
    Khan, Aamir J.
    [J]. PLOS ONE, 2016, 11 (11):